ICG2013
|
Patrick Van Beneden
|
|
 |
Belgium
|
|
Biography:
|
|
| Patrick Van Beneden has worked at Gimv since 1985 and has built a track record in life sciences, both in early stage and late stage investments and successful exits (such as Devgen, CropDesign, Plexxikon,…)He is currently serving on the Boards of ActoGeniX, Agrosavfe, Endosense, the Biotech Fund Flanders, Gimv Agri+ and FlandersBio, and is an observer at the board of directors of Jenavalve. Former BOD-seats include Devgen, Innogenetics, Crucell, Hypnion (acquired by Eli Lilly), CropDesign (acquired by BASF), Astex and Ablynx. Education: Masters degree in Financial Services (VLEKHO-Brussels). |
|